- Advice centres
- Research and Treatment
- ULTRASOUND
- Tomography, MRI, X-ray, mammography
- Laboratory
- Home Apnoea Test
- Aesthetic medicine, cosmetology
- Prenatal tests
- Surgery for obesity
- Surgical procedures
- Audiology - examinations and treatments
- Laryngology - examinations and treatments
- Other examinations and treatments
- Search for Examination or Treatment
- Doctors
- Patient's Essentials
- Posts
- News
- Contact
- Blog
- e-Store
Vaccination offer
To get the vaccination, book an appointment for a medical qualification
by calling 81 532 37 11.
Remember that the qualification is valid for 24 hours
from the time it is issued.
by calling 81 532 37 11.
Remember that the qualification is valid for 24 hours
from the time it is issued.
Meningococcus type B (Bexsero)
- Indications for use:
Bexsero vaccine is indicated for the active immunisation of children from 2 months of age, adolescents and adults against invasive meningococcal disease caused by Neisseria meningitidis group B. These bacteria can cause severe, life-threatening infections such as sepsis and meningitis. - Age indications:
from 2 months to 50 years - Vaccination cycle:
- from 2 months to 5 months of age - 3 doses not less than 1 month apart, a booster dose between 12-23 months of age,
- children from 6 months to 11 months of age - 2 doses not less than 2 months apart, a booster dose at 2 years of age,
- children from 12 months to 23 months - 2 doses not less than 2 months apart, booster dose 12-23 months after the primary vaccination,
- children from 2 years old to 10 years old - 2 doses not less than 2 months apart, no booster dose,
- children from 11 years of age and adults - 2 doses not less than 1 month apart, no booster dose, Qualification required before each dose.
- Vaccination price (one dose): PLN 390.00
Meningococci A, C, W135, Y (Nimenrix)
- Indication for use:
Nimenrix is a vaccine for the active immunisation of children (over 1 year of age), adolescents and adults exposed to Neisseriameningitidis serogroups A, C, W135 and Y; for the prevention of invasive disease. The meningitis bacteria can cause serious, sometimes life-threatening infections, such as meningitis and septicaemia (blood infection). - Persons to whom vaccination is particularly recommended:
- Persons residing in endemic areas
- Schoolchildren
- Children
- Age indications:
over 1 year of age. - Vaccination cycle:
1 dose. Qualification required. - Vaccination price: 210.00 zł
Meningococci A, C, W135, Y (Menveo)
- Indications for use:
Menveo is a vaccine for the active immunisation of children (over 2 years of age), adolescents and adults exposed to Neisseriameningitidis serogroups A, C, W135 and Y; for the prevention of invasive disease. The meningitis bacteria can cause serious, sometimes life-threatening infections, such as meningitis and septicaemia (blood infection). - Persons to whom vaccination is particularly recommended:
- Persons residing in endemic areas
- Schoolchildren
- Children
- Age indications:
from 2 years ofageto 65 years of age. - Vaccination cycle:
1 dose. Qualification required. - Vaccination price: £195.00
Meningokoki typ C (Neisvac C) - niedostępna do lutego 2023
- Indications for use:
Neisvac C is a vaccine for active immunization of children over 2 months of age, adolescents and adults against infections caused by Neisseria meningitidis group C. The vaccine does not protect against infections caused by meningococci of other groups. - Age indications:
after 2 months of age - Vaccination cycle:
- from 2 months of age to 12 months - 2 doses (the second dose 2 months after the first)
- children over 1 year of age, adults - 1 dose Qualification required before each dose.
- Duration of immunity:
For life - Vaccination price (one dose): 157.00 zł
